Work

Ovarian cancer proteomic biomarkers for pembrolizumab response

Year: 2025

Type: article

Abstract: To identify biomarkers in ovarian cancer that predict response to immune checkpoint inhibitors (ICI), which could be developed to guide future patient management.

Source: Gynecologic Oncology Reports

DOI: 10.1016/j.gore.2025.101831

Authors: Katherine Kleinberg, Erica V. Carballo, Andres A. Ocampo, Julia D. Wulfkuhle, Rosa I. Gallagher, Xiaopeng Sun, Dandi S. Huang, Christina Maxey, Brandie C. Taylor, Paula Gonzalez-Ericsson, Susan R. Opalenik, Emanuel Petricoin, BJ Rimel, Justin M. Balko, Courtney A. Penn

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $930

OpenAlex ID: W4414685126

FWCI:

Cites:

Cited by:

Related to: 10